Establishment and validation of a prognostic model for hepatocellular carcinoma after radical liver resection

被引:3
作者
Xu, Yan [1 ]
Zhang, Jianxian [2 ]
Bai, Yuhuan [1 ]
Jing, Changchun [1 ]
Zhang, Zhifeng [3 ]
Sun, Xiaoyu [3 ]
Yang, Dong [3 ]
Duan, Zhijun [3 ]
机构
[1] Second Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng 252600, Shandong, Peoples R China
[2] Second Peoples Hosp Liaocheng, Dept Gastrointestinal Surg, Liaocheng 252600, Shandong, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, 222 Zhongshan Rd, Dalian 116011, Peoples R China
来源
JOURNAL OF BUON | 2019年 / 24卷 / 04期
关键词
hepatocellular carcinoma (HCC); radical liver resection; survival analysis; Cox regression analysis; prognostic model; PREOPERATIVE ALPHA-FETOPROTEIN; HEPATITIS-B; STAGING SYSTEMS; POOR-PROGNOSIS; HEPATECTOMY; SURVIVAL; OVEREXPRESSION; PROLIFERATION; PROGRESSION; METASTASIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The prognostic factors related to survival of primary hepatocellular carcinoma (HCC) after radical resection were analyzed in order to establish a new prognostic model for HCC patients and to shed light on personalized treatments. Methods: 141 patients pathologically diagnosed as HCC were enrolled. The independent prognostic factors affecting overall survival were identified, and a prognostic mathematical model was established. Independent samples of 21 cases were used to validate the model's ability to predict prognosis of HCC patients. Results: The median survival time was 34 months, and the 1-, 3-, and 5-year overall survival rates were 93.2%, 80%, and 68.9%, respectively. Univariate analysis showed that alpha fetoprotein (AFP) serum level, tumor size, tumor capsule, liver cirrhosis, neutrophil-to-lymphocyte ratio (NLR), and total bilirubin (TBIL) were significantly correlated with overall survival (p<0.05). Cox multivariate analysis indicated that the independent prognostic factors were AFP serum level, liver cirrhosis, tumor size, tumor capsule, and NLR. The prognostic mathematical model was: Prognostic Index (PI)= 1.725 * liver cirrhosis + 0.783 * NLR + 1.046 * AFP + 0.595 * tumor size - 0.811 * tumor capsule. Based on the PI quartiles, 3.933 (25%), 4.716 (50%), and 5.195 (75%), the patients were divided into 4 groups: low risk (PI<3.933), moderate-risk (3.933 <= PI < 4.716), high-risk (4.761 <= PI < 5.195), and very high-risk (PI >= 5.195) group. The median survival times were 60, 34, 32, and 20 months, respectively. The 1-, 2-, 3-, and 5-year cumulative survival rates were 100%, 96%, 96%, 86%; 89%, 75%, 68%, 68%; 77%, 68%, 57%, 44%; 50%, 34%, 29%, 29%, separately. The predictions of the prognostic model demonstrated good consistency with the actual results. The total accuracy rate was 80.9%, and the Kappa consistency coefficient was 0.571 (p=0.009). Conclusions: The higher the PI, the lower the postoperative cumulative survival rate and the worse the prognosis. This model can be used as an effective method to assess the prognosis of HCC patients after resection.
引用
收藏
页码:1420 / 1428
页数:9
相关论文
共 47 条
  • [1] Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver
    Abdel-Wahab, Mohamed
    El-Husseiny, Tarek Salah
    El Hanafy, Ehab
    El Shobary, Mohamed
    Hamdy, Emad
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2010, 395 (06) : 625 - 632
  • [2] Bi Xinyu, 2014, Zhonghua Yi Xue Za Zhi, V94, P2645
  • [3] Assessing Prognostic Significance of Preoperative Alpha-Fetoprotein in Hepatitis B-Associated Hepatocellular Carcinoma: Normal is not the New Normal
    Blank, Sima
    Wang, Qin
    Fiel, M. Isabel
    Luan, Wei
    Kim, Ki Won
    Kadri, Hena
    Mandeli, John
    Hiotis, Spiros P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 986 - 994
  • [4] Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population
    Chan, Stephen L.
    Mo, Frankie K. F.
    Johnson, Philip J.
    Liem, Giok S.
    Chan, Tung C.
    Poon, Ming C.
    Ma, Brigette B. Y.
    Leung, Thomas W. T.
    Lai, Paul B. S.
    Chan, Anthony T. C.
    Mok, Tony S. K.
    Yeo, Winnie
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) : 340 - 347
  • [5] Chen L, 2017, J BUON, V22, P1525
  • [6] Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
    Chen, Liping
    Zhang, Qi
    Chang, Wenjun
    Du, Yan
    Zhang, Hongwei
    Cao, Guangwen
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1977 - 1987
  • [7] Chen Z, 2018, EUR REV MED PHARMACO, V22, P7222, DOI 10.26355/eurrev_201811_16256
  • [8] Hepatocellular carcinoma
    Forner, Alejandro
    Reig, Maria
    Bruix, Jordi
    [J]. LANCET, 2018, 391 (10127) : 1301 - 1314
  • [9] DLX4 as a prognostic marker for hepatocellular carcinoma
    Gao, Y.
    Li, Z.
    Guo, X.
    Liu, Y.
    Zhang, K.
    [J]. NEOPLASMA, 2014, 61 (03) : 318 - 323
  • [10] Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
    Garcea, G.
    Ladwa, N.
    Neal, C. P.
    Metcalfe, M. S.
    Dennison, A. R.
    Berry, D. P.
    [J]. WORLD JOURNAL OF SURGERY, 2011, 35 (04) : 868 - 872